# Study for Patients With Non Small Cell Lung Cancer (NSCLC)

> **NCT00168883** · PHASE2 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 80 (—)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel
- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT00168883
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 80 (—)
- **Last updated:** 2006-11-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00168883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00168883, "Study for Patients With Non Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00168883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*